Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Gonorrhoea is the second most notified sexually transmitted infection in the European Union and European Economic Area (EU/EEA) after chlamydia. The overall trend between 2008-2017 among 20 of the 28 EU/EEA countries consistently reporting, showed an increase in the number of notified gonorrhoea cases. In addition, over the past decades, Neisseria gonorrhoeae has developed antimicrobial resistance (AMR) to several antimicrobial classes.
Six years after the initial ECDC Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe, the threat of untreatable gonorrhoea remains. ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Preventing the emergence and spread of AMR in N. gonorrhoeae is just one aspect of gonorrhoea control: as part of comprehensive management strategies including appropriate treatment, diagnostics and testing algorithms (e.g., three-site testing in men who have sex with men), test of cure, notification and treatment of partners, enhanced focus on risk groups and STI prevention measures, including advocating for increased condom use.
Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe
This response plan is designed to prevent the spread of multidrug-resistant Neisseria gonorrhoeae (MDR NG) in the EU/EEA in the context of the possible emergence of untreatable gonorrhoea
Gonorrhoea is a sexually transmitted infection (STI) caused by Neisseria gonorrhoeae bacteria.Read more
Antimicrobial resistance is the ability of a microorganism (e.g., a bacterium, a virus) to resist the action of an antimicrobial agent. The major cause of antimicrobial resistance remains the use of antimicrobials in human medicine.Read more
Antimicrobial resistance/ microbiology - Gonorrhoea
The surveillance of gonococcal antimicrobial susceptibility surveillance in Europe is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform revisions of treatment guidelines. ECDC coordinates the Euro-GASP network.Read more
Developing a national strategy for the prevention and control of sexually transmitted infections
4 Sep 2019 - This report outlines suggested steps to develop, implement and coordinate a national STI strategy and action plan. It includes approaches to ensure the necessary stakeholder engagement for such strategies to succeed.
Gonorrhoea - Annual Epidemiological Report for 2017
25 Apr 2019 - A total of 89 239 cases of gonorrhoea were reported by 27 EU/EEA Member States for 2017.
Gonococcal antimicrobial susceptibility surveillance in Europe, 2017
28 Feb 2019 - The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2017 gonococcal antimicrobial susceptibility sentinel surveillance.